Validation of questionnaire for evaluation of ischemic stroke sequels – the Czech version of Stroke Impact Scale 3.0

Gurková, Elena; Šaňák, Daniel; Šáteková, Lenka; Šaňáková, Šárka; Zapletalová, Jana

doi:10.48095/cccsnn2022287

Cited by 2 publications

(4 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…SIS showed better psychometric properties (the responsiveness and criterion validity) in the patients undergoing stroke rehabilitation [17]; thus, it seemed to be more suited for the assessing HRQoL in IS patients. Furthermore, our study aim covered a broad range of variables explaining multidimensional long-term sequels after IS, and we preferred a reliable, stroke-specific HRQoL and language-validated tool [14].…”

Section: Discussionmentioning

confidence: 99%

“…All patients completed a questionnaire set that included SIS 3.0 [13] and the Hospital Anxiety and Depression Scale (HADS [12]). The psychometric properties of the Czech version of SIS 3.0 have been reported in the previous validation study [14]. A composite of physical SIS domains, which consisted of all physical subscales of SIS 3.0 (strength, hand function, activities of daily living [ADL]/instrumental activities of daily living, and mobility), was used to operationalize the overall level of physical ability and ADLs [15].…”

Section: Methodsmentioning

confidence: 99%

See 1 more Smart Citation

Quality of Life in Patients with Excellent 3-Month Clinical Outcome after First-Ever Ischemic Stroke: A Time to Redefine Excellent Outcome?

Šaňák,

Gurková,

Štureková

et al. 2024

Eur Neurol

Self Cite

View full text Add to dashboard Cite

Background and aims: Ischemic stroke (IS) may have impact on long-term health-related quality of life (HRQoL) even in the patients with good clinical outcome, and tools mostly used for the assessment of outcome may underestimate or not reflect all relevant sequels after IS. We aimed to analyse HRQoL in the patients with excellent outcome after IS. Methods: We analysed consecutive IS patients enrolled in the prospective FRAILTY study (ClinicalTrials.gov: NCT04839887) with excellent three-month clinical outcome (score 0-1 in modified Rankin Scale, mRS). Stroke Impact Scale (SIS) version 3.0 and Hospital Anxiety and Depression Scale (HADS) were used for the HRQoL, anxiety and depression assessments, and subgroup comparisons were performed according to NIHSS score (0, ≥1), age (50 <, ≥ 50 years) and sex. Results: In total, 158 patients (55.7% men, mean age 60.3 ± 13.4 years) were analysed and 72.2% of them had score 0 in mRS. The overall lowest median scores were found in the SIS domain “emotion”, “strength” and “participation”. Patients with NIHSS ≥ 1 had lower scores in all SIS domains except “emotions” and “mobility”. Patients ≥ 50 years had lower score in “mobility” (p=0.004), and females in domain of “social participation” (p=0.044). No differences were found among all subgroups in HADS anxiety and depression. Age, NIHSS score and depression were found negative predictors for the physical domains of HRQoL. Conclusions: Despite excellent three-month clinical outcome after IS, patients had affected substantially their HRQoL, especially those with NIHSS ≥ 1. Patients ≥ 50 years had more affected “mobility” and females “social participation”.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Methodsmentioning

confidence: 99%

Quality of Life in Patients with Excellent 3-Month Clinical Outcome after First-Ever Ischemic Stroke: A Time to Redefine Excellent Outcome?

Šaňák,

Gurková,

Štureková

et al. 2024

Eur Neurol

Self Cite

View full text Add to dashboard Cite

show abstract

“…voiding disorders, depression, anxiety states, cognitive disorders, chronic fatigue), and last but not least, they also need help and support in dealing with various social problems. In this context, the assessment of the quality of life of patients with SM becomes particularly important [26][27][28]. At present, it is not yet possible to cure the disease.…”

Section: Discussionmentioning

confidence: 99%

“…These assessments very often differ from those of the patients themselves, and it is known that carers often rate QoL more pessimistically and, consequently, more poorly than the patients themselves [28]. In clinical practice, the current state of QoL assessment in patients with MS is characterized by considerable inconsistency and numerous differences in the use of assessment tools [6].…”

Section: Discussionmentioning

confidence: 99%

Validation of the Multiple Sclerosis Quality of Life Questionnaire-54 in Slovakia

Majerníková,

Obročníková,

Hudáková

et al. 2024

hpc

View full text Add to dashboard Cite

Background. Quality of life assessment of patients with multiple sclerosis (MS) is not commonly performed in the Slovak Republic due to the unavailability of a validated Slovak version of a specific assessment tool. Material and methods. The aim of this study was to transculturally adapt and validate the Slovak version of the Multiple Sclerosis Quality of Life Questionnaire (MSQoL-54). Psychometric analysis was performed by assessing reliability (Cronbach α), internal validation and external validation by measuring correlation with clinical factors such Expanded Disability Status Scale (EDSS) as well as other demographic factors. The questionnaire was validated on a sample of 298 patients with MS.Results. Based on the results of the factor analysis, it can be concluded that the Slovak version of the MSQoL-54 questionnaire has comparable psychometric properties to the original version. External validation using EDSS showed a statistically significant inverse (negative) correlation on all components of the questionnaire.

show abstract

Validation of questionnaire for evaluation of ischemic stroke sequels – the Czech version of Stroke Impact Scale 3.0

Cited by 2 publications

References 0 publications

Quality of Life in Patients with Excellent 3-Month Clinical Outcome after First-Ever Ischemic Stroke: A Time to Redefine Excellent Outcome?

Quality of Life in Patients with Excellent 3-Month Clinical Outcome after First-Ever Ischemic Stroke: A Time to Redefine Excellent Outcome?

Validation of the Multiple Sclerosis Quality of Life Questionnaire-54 in Slovakia

Contact Info

Product

Resources

About